Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment

Irina N. Shipounova, PhD, Nataliya A. Petinati, MD PhD, Nina J. Drize, PhD, Aminat A. Magomedova, MD PhD, Ekaterina A. Fastova, MD, Sergey K. Kravchenko, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anna G. Turkina, Prof., MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5014.

https://doi.org/10.1182/blood-2019-123396

Published: 2019

Journal Articles

Separate Roles of Asparagine and Glutamine in Cytostatic Effect of L-Asparaginase - Stable Isotope Tracing Approach

Katerina Hlozkova, PhD, Alpesh Thakker, PhD, Natividad Alquézar-Artieda, Marketa Zaliova, MD PhD, Jan Trka, Prof., MD PhD, Daniel A Tennant, PhD, Julia Starkova, PhD

Blood (2019) 134 (Supplement_1): 2575.

https://doi.org/10.1182/blood-2019-127911

Published: 2019

Journal Articles

Predictors of Efficacy for Blinatumomab in BCP-ALL Patients: Non-Responders Show Impaired CD19-BiTE®-Mediated Cytotoxicity in Vitro

Veit Bücklein, MD, Michaela Scheurer, Bettina Brauchle, MSc, Roman Kischel, MD, Michael von Bergwelt, Karsten Spiekermann, MD, Marion Subklewe, MD

Blood (2019) 134 (Supplement_1): 2632.

https://doi.org/10.1182/blood-2019-129057

Published: 2019

Journal Articles

IGF1R-IRS1/2 Signaling Pathway Is a Potential Target for FLT3-Mutated Acute Myeloid Leukemia

Juan L Coelho-Silva, BSc, MSc, Diego A Pereira-Martins, MSc, Virginia Campos Silvestrini, BSc, MSc, Eduardo M Rego, MD PhD, Vitor Marcel Faca, PhD, João Agostinho Machado-Neto, PhD, Fabiola Traina, MD PhD

Blood (2019) 134 (Supplement_1): 2689.

https://doi.org/10.1182/blood-2019-132129

Published: 2019

Journal Articles

Hypomethylating Agents and Casein Kinase 2 Inhibitor Act Synergistic and Reveal Significant Anti-Leukemic Effects in Acute Lymphoblastic Leukemia Cells

Catrin Roolf, PhD, Anna Richter, M.Sc., Christoph Konkolefski, Yascha Khodamoradi, Gudrun Knuebel, Anett Sekora, Jan Stenzel, PhD, Bernd Joachim Krause, MD, Brigitte Vollmar, MD, Irmela Jeremias, MD, Jens P. Panse, MD, Hugo Murua Escobar, PhD, Christian Junghanss, MD

Blood (2016) 128 (22): 2804.

https://doi.org/10.1182/blood.V128.22.2804.2804

Published: 2016

Journal Articles

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa A. Kuzmina, MD PhD, Galina Baskhaeva, MD, Kseniia Zarubina, MD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 2805.

https://doi.org/10.1182/blood.V128.22.2805.2805

Published: 2016

Journal Articles

Targeting the ER-Mitochondrial Interface of Cell Death Sensitizes Leukemia Cells Towards Cytostatics

Fabian Koczian, Jan Vomacka, Binje Vick, PhD, Britta F Hettich, Uli Kazmaier, Stephan A Sieber, Irmela Jeremias, MD, Angelika M Vollmar, Simone Braig

Blood (2016) 128 (22): 2319.

https://doi.org/10.1182/blood.V128.22.2319.2319

Published: 2016

Journal Articles

Chemotherapy-Induced Nausea and Vomiting (CINV) - First Results of a German Non-Interventional Study with NEPA - a Netupitant/Palonosetron Fixed Dose Combination

Meinolf Karthaus, P Klare, V Heilmann, G Klausmann, Joerg Schilling

Blood (2016) 128 (22): 3614.

https://doi.org/10.1182/blood.V128.22.3614.3614

Published: 2016

Journal Articles

Pro-Coagulant and Pro-Inflammatory Effect of Interferon Alpha in Myeloproliferative Neoplasms

Nadine Ajzenberg, MD PhD, Dorothee Faille, PharmD, PhD, Lamia Lamrani, PhD, Stéphane Loyau, Marie-Geneviève Huisse, MD PhD, Nicolas Dumontier, PharmD, Martine Jandrot-Perrus, MD PhD, Sawsaneh Alkhaier, Bruno Cassinat, PharmD, PhD, Christine Chomienne, MD PhD, Christine Dosquet, MD PhD

Blood (2016) 128 (22): 1941.

https://doi.org/10.1182/blood.V128.22.1941.1941

Published: 2016

Journal Articles

The Different Treatment Approaches in Younger Patients with Angioimmunoblastic T-Cell Lymphoma

Natalia G. Chernova, MD PhD, Yulia E. Vinogradova, MD PhD, Eugene E. Zvonkov, MD PhD, Yulia V. Sidorova, MD PhD, Alla Kovrigina, MD PhD, Alla Kovrigina, MD PhD, Elena N. Parovichnikova, MD PhD, Elena N. Parovichnikova, MD PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 5345.

https://doi.org/10.1182/blood.V128.22.5345.5345

Published: 2016

Journal Articles

B-Cell Precursor Acute Lymphoblastic Leukemia Cells Create a Self-Reinforcing Niche Independent of the CXCR4/CXCL12 Axis

Bob de Rooij, MSc, Roel Polak, MD, Rob Pieters, MD PhD, Monique L. Den Boer, PhD

Blood (2015) 126 (23): 1297.

https://doi.org/10.1182/blood.V126.23.1297.1297

Published: 2015

Journal Articles

Potent Inhibition of the Growth and Induction of Apoptosis in Lymphoma By the Anthelminthic Drug Niclosamide: In Vitro Data

Junaid Ansari, MD, Paula Polk, Jeffrey Aufman, MD, Guillermo A Herrera, MD, James Cardelli, PhD, Reinhold Munker, MD

Blood (2015) 126 (23): 5131.

https://doi.org/10.1182/blood.V126.23.5131.5131

Published: 2015

Journal Articles

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Nicola Stefano Fracchiolla, MD, Elisabetta Todisco, MD PhD, Andrea Bilancia, Sara Gandolfi, MD, Valentina Mancini, MD, Laura Marbello, MD, Massimo Bernardi, MD, Andrea Assanelli, MD, Nicola Orofino, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Francesca Guidotti, MD, Roberto Cairoli, MD, Fabio Ciceri, MD, Armando Santoro, MD, Agostino Cortelezzi, MD, Giuseppe Rossi, MD

Blood (2015) 126 (23): 5611.

https://doi.org/10.1182/blood.V126.23.5611.5611

Published: 2015

Journal Articles

Aspirin in Philadelphia-Negative Myeloproliferative Neoplasms: What Is the Optimal Dose ?

Nadine Ajzenberg, MD PhD, Dorothee Faille, PharmD, PhD, Marie-Genevieve Huisse, MD PhD, Anh Hong Cung, Pharm D, Lamia Lamrani, Nicolas Dumontier, Pharm D, Martine Jandrot-Perrus, MD PhD, Bruno Cassinat, PharmD, PhD, Christine Chomienne, MD PhD, Christine Dosquet, MD PhD

Blood (2014) 124 (21): 3200.

https://doi.org/10.1182/blood.V124.21.3200.3200

Published: 2014

Journal Articles

High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group

Gerald Illerhaus, MD, Kristina Fritsch, MD, Ingo Schmidt-Wolf, MD, Roland Schroers, MD, Gerlinde Egerer, MD, Agnieszka Korfel, MD, Tobias Birnbaum, MD, Monika Lamprecht, MD, Nikolas von Bubnoff, Hans-Heinrich Wolf, MD, Stephan Stilgenbauer, MD, Martin Trepel, MD PhD, Robert Möhle, MD, Claudia Hader, MD, Gabriele Ihorst, Heidi Fricker, Benjamin Kasenda, MD, Elisabeth Schorb, MD, Jürgen Finke, MD

Blood (2014) 124 (21): 2527.

https://doi.org/10.1182/blood.V124.21.2527.2527

Published: 2014

Journal Articles

Flow Cytometry For Platelet Function Assessment In Essential Thrombocythemia : Does Total Amount Of Platelets Makes Up For Individual Platelet Defect ?

Nathalie Hezard, MD, PhD, Bernard Pignon, MD, Jean Claude Adjizian, MD, Catherine Mace, Alain Delmer, MD, Philippe Nguyen, MD, PhD

Blood (2013) 122 (21): 4089.

https://doi.org/10.1182/blood.V122.21.4089.4089

Published: 2013

Journal Articles

Smac Mimetic-Mediated Sensitization Of Childhood ALL Cells For Drug-Induced Apoptosis Independent Of TNFα and NFκB Signaling Pathways

Karin Schmelz, PhD, Nina Weichert, MD, Jutta Proba, Marie-Sophie Erdmann, Patrick Hundsdoerfer, MD

Blood (2013) 122 (21): 2911.

https://doi.org/10.1182/blood.V122.21.2911.2911

Published: 2013

Journal Articles

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Blood (2012) 120 (21): 1855.

https://doi.org/10.1182/blood.V120.21.1855.1855

Published: 2012

Journal Articles

Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 M utations to Chemotherapy.

Jana Zemanova, Ludmila Sebejova, Dr., Ondrej Hylse, Kamil Paruch, Ph.D., Sarka Pavlova, Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD, Prof., Martin Trbusek, Dr., PhD.

Blood (2012) 120 (21): 2460.

https://doi.org/10.1182/blood.V120.21.2460.2460

Published: 2012

Journal Articles

Clofarabine in the Frontline Treatment of Childhood Acute Lymphoblastic Leukemia. Results of the COALL 08–09 Study Regarding Safety and Efficacy of Clofarabine in Combination with Asparaginase During Consolidation Therapy.

Gabriele Escherich, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2012) 120 (21): 2606.

https://doi.org/10.1182/blood.V120.21.2606.2606

Published: 2012

NARROW

Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment

Separate Roles of Asparagine and Glutamine in Cytostatic Effect of L-Asparaginase - Stable Isotope Tracing Approach

Predictors of Efficacy for Blinatumomab in BCP-ALL Patients: Non-Responders Show Impaired CD19-BiTE®-Mediated Cytotoxicity in Vitro

IGF1R-IRS1/2 Signaling Pathway Is a Potential Target for FLT3-Mutated Acute Myeloid Leukemia

Hypomethylating Agents and Casein Kinase 2 Inhibitor Act Synergistic and Reveal Significant Anti-Leukemic Effects in Acute Lymphoblastic Leukemia Cells

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Targeting the ER-Mitochondrial Interface of Cell Death Sensitizes Leukemia Cells Towards Cytostatics

Chemotherapy-Induced Nausea and Vomiting (CINV) - First Results of a German Non-Interventional Study with NEPA - a Netupitant/Palonosetron Fixed Dose Combination

Pro-Coagulant and Pro-Inflammatory Effect of Interferon Alpha in Myeloproliferative Neoplasms

The Different Treatment Approaches in Younger Patients with Angioimmunoblastic T-Cell Lymphoma

B-Cell Precursor Acute Lymphoblastic Leukemia Cells Create a Self-Reinforcing Niche Independent of the CXCR4/CXCL12 Axis

Potent Inhibition of the Growth and Induction of Apoptosis in Lymphoma By the Anthelminthic Drug Niclosamide: In Vitro Data

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Aspirin in Philadelphia-Negative Myeloproliferative Neoplasms: What Is the Optimal Dose ?

High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group

Flow Cytometry For Platelet Function Assessment In Essential Thrombocythemia : Does Total Amount Of Platelets Makes Up For Individual Platelet Defect ?

Smac Mimetic-Mediated Sensitization Of Childhood ALL Cells For Drug-Induced Apoptosis Independent Of TNFα and NFκB Signaling Pathways

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 M utations to Chemotherapy.

Clofarabine in the Frontline Treatment of Childhood Acute Lymphoblastic Leukemia. Results of the COALL 08–09 Study Regarding Safety and Efficacy of Clofarabine in Combination with Asparaginase During Consolidation Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only